Replies to post #9388 on Moderna Inc (MRNA)

[axelvento]

Here is what Baron Funds has to say about Moderna, Inc. in its Q3 2021 investor letter:

"Moderna, Inc. is a leader in the emerging field of mRNA-based vaccines and therapeutics. Shares performed well for the quarter. Moderna has been one of the most successful companies in the race to develop and provide a COVID-19 vaccine and is focusing on introducing a COVID-19 booster combined with the flu shot. With the COVID-19 vaccine success under its belt, we think Moderna has potential to disrupt the entire biopharmaceutical industry, from infectious disease vaccines to oncology and rare disease treatment."



https://d2gr5kl7dt2z3t.cloudfront.net/blog/wp-content/uploads/2021/11/06115531/Baron-Health-Care-Funds-Q3-2021-Investor-Letter.pdf


$MRNA

Moderna's President Just Gave Us a Clue About the Size of Tomorrow's Vaccine Market

Moderna is working on one potential product that could push the masses to go for a shot. The company is developing a combination flu/coronavirus/allergies vaccine. Moderna currently is studying the flu/coronavirus candidate in preclinical tests. But during its earnings call, the company said the goal is to add allergy to the mix.

By packaging the coronavirus vaccine with an allergy vaccine, Moderna is sure to increase its target audience down the road. As much as 30% of the world's population suffers from seasonal allergies, according to the American Academy of Allergy, Asthma, & Immunology.

https://www.fool.com/investing/2021/11/07/moderna-gives-clue-about-future-market-size/?source=eptyholnk0000202&utm_source=yahoo-host&utm_medium=feed&utm_campaign=article